One month to go before Cannabis Europa!

The exhibition Cannabis Europa London 2023 will be held in four weeks' time, at a time when the emergence of a potential European cannabis market is attracting a great deal of interest.

Changing attitudes towards cannabis, economic forces and heightened sensitivity to social justice issues are just some of the factors tipping the balance towards the legalization of adult use in Europe.

Sales of legal cannabis for adult use in Europe could reach 1.6 billion euros by 2027 if Germany legalized the sale of cannabis, and taking into account cannabis regulations in the Czech Republic, Switzerland and the Netherlands.

Over the same period, the medical cannabis patient population is expected to grow in countries such as France, the UK and Poland, bringing the total number of medical cannabis patients in Europe to around 1.43 million, an increase of 234 % over the forecast period (2023-2027).

This is the backdrop to Cannabis Europa, Europe's leading cannabis policy event, returns to London on May 2 and 3, 2023, at London's Barbican Centre. The annual event will bring together over 1,500 policymakers, industry operators, investors and advocates from more than 37 nations to discuss the state of the industry and the global opportunities emerging in the region.

Dorien Rookmaker, Member of the European Parliament from the Netherlands, who will be taking part in the «EU Better Believe It» round table, pointed out that there are big questions ahead for the sector. «The increasing legalization of the medical and recreational use of cannabis has created huge opportunities worldwide. International standards and improved legislation are of great importance. What are the next steps?»

Cannabis Europa will analyze the market's main growth drivers, as well as the opportunities and challenges ahead. Chief among these is the timing of the legalizing cannabis in Europe and how regulations will impact market speed and growth.

«Even if it seems slow, Europe is on the verge of creating a new way of dealing with cannabis - fair, accessible, but still highly regulated,» said Dirk Heitepriem, Vice President of the German Cannabis Industry Association, who will be speaking at the «State of the Art Session: Germany».

The European cannabis market has always been stricter than the US market in terms of product diversity and access, even for medical use, and this is unlikely to change, even if the laws surrounding the substance evolve for safety reasons. Despite this, combined sales of CBD, medical cannabis and adult-use cannabis will reach nearly 6.5 billion euros by 2027, according to the latest report from Prohibition Partners, the group behind Cannabis Europa.

«Prohibition seems to have completely failed in the cannabis sector, and the market has not only stabilized, but is also growing. That's why we need to find better instruments of control. A strictly regulated market can regulate what is produced, where, by whom and how much is sold. A total ban can't do that,» explains Czech national drug coordinator Jindrich Voboril. «A regulated market has greater potential for harm prevention.».

The two-day program will feature a prestigious group of advocates, innovators, policymakers and investors who will engage in meaningful conversations about how to move this market forward.

You can get a discount on your tickets with the following codes:

• 15% VIP Ticket Discount : NEWSWEED15
• 10% Standard Ticket Discount : 10NEWSWEED

To find out more about Cannabis Europa and register for the event, you can visit their website at www.cannabis-europa.com

Why go to Cannabis Europa?

Cannabis Europa brings to the stage some of the most prominent voices in the global industry, the leaders and pioneers shaping the future of cannabis in Europe.

Since 2018, Cannabis Europa is Europe's premier cannabis event, attracting over 1,500 participants from more than 37 countries for two days of industry information and networking. At this event, participants have a unique chance to connect with influential leaders of successful cannabis businesses, investors actively working in the market and key policy makers.

This powerful combination of industry expertise, financial acumen and political influence is precisely what the European cannabis industry needs to move forward.